Cc1cc(NC(=O)NC(=O)c2ccccc2NC(=O)CN(C)C)ccc1Oc1ncc(Br)cn1.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?